Cue Biopharma
$13.359876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.26 (-1.91%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Cue Biopharma and other stocks, options, and ETFs commission-free!
About CUE
Cue Biopharma, Inc. Common Stock, also called Cue Biopharma, is a biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded on December 31, 2014 and is headquartered in Cambridge, MA. The listed name for CUE is Cue Biopharma, Inc. Common Stock.
CEO
Daniel R. Passeri
Employees
47
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
411.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
293.68K
High Today
$13.95
Low Today
$13.03
Open Price
$13.37
Volume
223.69K
52 Week High
$31.69
52 Week Low
$9.30
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
CUE Earnings
-$0.48
-$0.32
-$0.16
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, After Hours